Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 1423053 MIAMI, FL
Back to CGEM Full portfolio

Position in CGEM

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$7,238,183
+$3,646,209 QoQ
Shares Held
397,484
+57.2% QoQ
Ownership
0.618%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 183 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CGEM Over Time

Shares Held

Position Value (USD)

Derivatives in CGEM

reported options exposure · as of Jun 30, 2026
CallValue
$919,605
CallShares
50,500
PutValue
$1,187,292
PutShares
65,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,763,744 across 435 Biotechnology names. CGEM ranks #117 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in CGEM

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,187,292 65,200
2026-06-30 $919,605 50,500
2026-06-30 $7,238,183 397,484
2026-03-31 $3,591,974 252,778
2026-03-31 $562,716 39,600
2025-12-31 $852,840 82,400
2025-12-31 $1,141,780 110,317
2025-09-30 $11,767,533 1,984,407
2025-06-30 $19,681,108 2,613,693
2025-06-30 $1,234,167 163,900
2025-03-31 $34,822 4,600
2025-03-31 $135,503 17,900
2025-03-31 $20,795,886 2,747,145
2024-12-31 $32,677,769 2,682,904
2024-12-31 $263,088 21,600
2024-12-31 $270,396 22,200
2024-09-30 $32,731,002 1,955,257
2024-09-30 $679,644 40,600
2024-09-30 $475,416 28,400
2024-06-30 $277,296 15,900
2024-06-30 $33,888,344 1,943,139
2024-06-30 $594,704 34,100
2024-03-31 $214,704 12,600
2024-03-31 $18,900,273 1,109,171
2024-03-31 $83,496 4,900
2023-12-31 $11,544,138 1,132,889
2023-12-31 $75,406 7,400
2023-12-31 $83,558 8,200
2023-09-30 $9,638,683 1,065,048
2023-09-30 $36,200 4,000
2023-09-30 $60,635 6,700
2023-06-30 $22,596 2,100
2023-06-30 $11,366,335 1,056,351
2023-06-30 $33,356 3,100
2023-03-31 $15,345 1,500
2023-03-31 $28,644 2,800
2023-03-31 $6,373,985 623,068
2022-12-31 $3,165 300
2022-12-31 $12,660 1,200
2022-12-31 $2,585,909 245,110
2022-09-30 $338,448 26,400
2022-09-30 $3,020,430 235,603
2022-06-30 $351,268 27,400
2022-06-30 $4,736,604 369,470
2022-03-31 $1,353,771 129,300
2022-03-31 $1,462,501 139,685
2021-12-31 $717,201 46,481
2021-09-30 $2,395,421 106,133
2021-06-30 $2,655,030 103,108
2021-03-31 $4,638,787 111,322